00575.HK
Regent Pacific Group Limited
HKSE · Healthcare · Asset Management · HK
HKD 0.85
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.3M | 363.0K | 719.0K | 382.0K | 114.0K |
| Cost of Revenue | 1.2M | 783.0K | 938.0K | 2.7M | 3.0M |
| Gross Profit | 5.1M | (420.0K) | (219.0K) | (2.3M) | (1.1M) |
| Operating Expenses | |||||
| R&D Expense | 1.2M | 783.0K | 938.0K | 1.4M | 1.2M |
| SG&A Expense | 4.6M | 389.0K | 565.0K | 703.0K | 863.0K |
| General & Admin Expense | 1.1M | 367.0K | 551.0K | 670.0K | 813.0K |
| Selling & Marketing Expense | 52.0K | 22.0K | 14.0K | 33.0K | 50.0K |
| Other Expenses | 3.1M | 2.7M | 2.6M | 26.0M | 31.8M |
| Total Operating Expenses | 8.8M | 3.9M | 4.1M | 28.0M | 33.9M |
| Cost and Expenses | 10.0M | 4.7M | 5.1M | 30.8M | 35.1M |
| Operating Income (EBIT) | (3.7M) | (4.3M) | (4.3M) | (30.4M) | (35.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 811.5K | 368.5K | 171.0K | 80.0K | 1.0M |
| Net Interest Income | (811.2K) | (368.0K) | (171.0K) | (80.0K) | (1.0M) |
| Other Non-Op Income/Expense | (1.8M) | (398.0K) | (171.0K) | (80.0K) | (1.0M) |
| Non-Operating Income (excl Interest) | 896.6K | (15.0K) | (145.0K) | 2.4M | 4.2M |
| EBT (Pre-Tax Income) | (5.6M) | (4.7M) | (4.5M) | (30.5M) | (36.0M) |
| Income Tax Expense | 472.8K | — | (26.0K) | (5.4M) | 419.0K |
| Bottom Line | |||||
| Net Income | (6.0M) | (4.7M) | (4.5M) | (25.0M) | (36.4M) |
| Earnings from Cont. Ops | (6.0M) | (4.7M) | (4.5M) | (25.0M) | (36.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (6.0M) | (4.7M) | (4.5M) | (25.0M) | (36.4M) |
| Per Share | |||||
| Basic EPS | (HK$0.02) | (HK$0.02) | (HK$0.02) | (HK$0.11) | (HK$0.30) |
| Diluted EPS | (HK$0.02) | (HK$0.02) | (HK$0.02) | (HK$0.11) | (HK$0.30) |
| Revenue Per Share | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| Shares | |||||
| Basic Shares Outstanding | 291.8M | 261.4M | 228.4M | 225.1M | 119.8M |
| Diluted Shares Outstanding | 291.8M | 261.4M | 228.4M | 225.1M | 120.0M |
| Profitability Metrics | |||||
| EBITDA | 17.6M | (4.3M) | 18.0M | (7.7M) | (9.6M) |
| D&A | 22.2M | 8.0K | 22.2M | 22.7M | 25.4M |
| EBIT | (4.6M) | (4.3M) | (4.2M) | (30.4M) | (35.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026